
John Kwoka, Neal F. Finnegan Distinguished Professor of Economics has been named Chief Economist to Federal Trade Commission (FTC) Chair Lina Khan. During his appointment to the FTC, Kwoka will be working with competition economists and attorneys on an updated approach to merger review policies.
John Kwoka will serve as Chief Economist to the Chair. John joins the FTC from Northeastern University where he is the Neal F. Finnegan Distinguished Professor of Economics. Kwoka has published widely, with his recent scholarship focusing on ways to update and strengthen merger policy and other aspects of antitrust. Kwoka has previously taught at the University of North Carolina at Chapel Hill and George Washington University, and has had visiting positions at Northwestern University and Harvard University. He has lectured and consulted widely in the areas of industrial and competition policy and has published more than 85 research and policy papers on economic issues.
John Kwoka was also part our of editorial board and published Controlling Mergers and Market Power: A Program for Reviving Antitrust in America with CPI. This an important and timely contribution from a prominent antitrust economist and policy advisor.
Controlling Mergers and Market Power sets out a comprehensive, detailed, and rigorous program to revive antitrust, and merger control in particular, in the U.S. It analyzes the specific failures and weaknesses of current policy.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas